Week of July 11, 2023 | Vol. 12, Issue 27

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Pharma Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

New FDA Clarification Allows Wholesale by 503B Facilities to 503A Pharmacies

Pharma Solutions

Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich

PR Newswire - Jul 3, 2023

Labcorp forms spin-off of Fortrea

Pharmaceutical Technology - Jul 4, 2023

NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva

Globe Newswire - Jul 3, 2023

Moderna strikes deal worth up to $1B to develop, produce mRNA drugs in China: reports

Fierce Pharma - Jul 5, 2023

LIFERA, SANOFI and ARABIO Sign MOU to Manufacture and Supply Vaccines in Saudi Arabia, Boosting Local Production with a New State-Of-The-Art Manufacturing Facility

PR Newswire - Jul 5, 2023

Samsung Biologics, Pfizer expand biosimilar production partnership with pair of deals worth $897M

Fierce Pharma - Jul 5, 2023

Audax Private Equity Announces Agreement to Sell CorEvitas to Thermo Fisher Scientific

Business Wire - Jul 6, 2023

Takeda, F-star Therapeutics Partner to Advance Immunotherapies

Contract Pharma - Jul 6, 2023

Thermo Fisher agrees to acquire CorEvitas for $913m

Pharmaceutical Technology - Jul 7, 2023

TANNER NEWS

A Mission to Improve Patient Access

Tanner Pharma Group was founded two decades ago specifically to improve patient access to life-saving medicines. Tanner operates around the world, working with manufacturers, non-profit organizations, physicians and health authorities to get treatments to patients on the ground while navigating issues that include regulations, languages, supplies, and logistics. Read more.